About RareCyte
RareCyte is a private company based in Seattle, Washington. It has reported $79,777,672 raised in five offerings on Form D since August 2017. Its chief executive is Joseph Victor Jr..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 12, 2023 | Jul 25, 2023 | $13,174,795of $35.6M target | 19 | $693K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 19, 2021 | Sep 10, 2021 | $24,046,147fully sold | 27 | $890K | EquityRule 506(b) | Form D ↗ |
| Dec 11, 2019 | Dec 26, 2019 | $22,156,736fully sold | 0 | — | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| May 10, 2018 | May 24, 2018 | $4,999,999fully sold | 1 | $4.9M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 27, 2017 | Aug 10, 2017 | $15,399,995of $16.3M target | 9 | $1.7M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $79,777,672 | |||||
The filing for the offering first filed Dec 26, 2019 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on RareCyte's Form D filed Jul 25, 2023.
Earlier filings also listed Jim Cooper (executive officer, last listed Dec 2019), Frank Witney (director, last listed Dec 2019), Robert Shepler (director, last listed May 2018), Eric Kaldjian (executive officer, last listed May 2018), Brian Daniels (director, last listed May 2018) and Evan Castiglia (executive officer, last listed Aug 2017).